N Kranzhöfer

426 total citations
7 papers, 310 citations indexed

About

N Kranzhöfer is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, N Kranzhöfer has authored 7 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Genetics. Recurrent topics in N Kranzhöfer's work include Chronic Lymphocytic Leukemia Research (2 papers), Breast Cancer Treatment Studies (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). N Kranzhöfer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Breast Cancer Treatment Studies (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). N Kranzhöfer collaborates with scholars based in Germany and France. N Kranzhöfer's co-authors include Raymonde Busch, Barbara Eichhorst, Michael Hallek, Anna‐Maria Fink, Martina Stauch, Matthias Ritgen, Kirsten Fischer, Clemens‐Martin Wendtner, Valentin Goede and Carmen D. Schweighofer and has published in prestigious journals such as Blood, Bone Marrow Transplantation and Archives of Gynecology and Obstetrics.

In The Last Decade

N Kranzhöfer

7 papers receiving 300 citations

Peers

Countries citing papers authored by N Kranzhöfer

Since Specialization

Citations

This map shows the geographic impact of N Kranzhöfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Kranzhöfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Kranzhöfer more than expected).

Fields of papers citing papers by N Kranzhöfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Kranzhöfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Kranzhöfer. The network helps show where N Kranzhöfer may publish in the future.

Co-authorship network of co-authors of N Kranzhöfer

This figure shows the co-authorship network connecting the top 25 collaborators of N Kranzhöfer. A scholar is included among the top collaborators of N Kranzhöfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Kranzhöfer. N Kranzhöfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Secondary hemophagocytic lymphohistiocytosis associated with adjuvant pembrolizumab therapy in a young patient with triple-negative breast cancer: a case report with literature review 2025 ·Archives of Gynecology and Obstetrics ·(unknown), Meletios P. Nigdelis, (unknown), (unknown), Moritz Bewarder, Joerg Thomas Bittenbring, N Kranzhöfer, Lorenz Thurner, Yong‐Jae Kim, Anita Seibold, (unknown)	1
2	Therapy of isolated locoregional recurrent carcinoma of the breast 2019 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), (unknown), Patrick Melchior, (unknown), G Schmidt, N Kranzhöfer, Erich‐Franz Solomayer, (unknown), G. P. Breitbach	3
3	Trastuzumab (herceptin): a retrospective analysis of the effects of long-term application in a series of patients with breast cancer 2014 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), (unknown), N Kranzhöfer, (unknown), Erich‐Franz Solomayer, (unknown)	2
4	First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia 2009 ·Blood ·Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer, Martina Stauch, Manuela A. Bergmann, Matthias Ritgen, N Kranzhöfer, Robert Rohrberg, Ulrike Söling, Oswald Burkhard, Anne Westermann, Valentin Goede, Carmen D. Schweighofer, Kirsten Fischer, Anna‐Maria Fink, Clemens‐Martin Wendtner, Günter Brittinger, Hartmut Döhner, Bertold Emmerich, Michael Hallek, (unknown)	238
5	No Significant Clinical Benefit of First Line Therapy with Fludarabine (F) in Comparison to Chlorambucil (Clb) in Elderly Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Results of a Phase III Study of the German CLL Study Group (GCLLSG). 2007 ·Blood ·Barbara Eichhorst, Raymonde Busch, Martina Stauch, Michael Bergmann, Matthias Ritgen, N Kranzhöfer, Carmen D. Schweighofer, Kirsten Fischer, Anna‐Maria Fink, Paula Cramer, Valentin Goede, Clemens‐Martin Wendtner, Michael Hallek, (unknown)	21
6	First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients 2000 ·Bone Marrow Transplantation ·(unknown), N Kranzhöfer, Michael Pfreundschuh, (unknown), (unknown)	18
7	Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation 1998 ·Bone Marrow Transplantation ·M. Michallet, Florence Persat, N Kranzhöfer, J. C. Levron, (unknown), Amine Belhabri, (unknown), (unknown), D Fière, M. A. Piens	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact